Follow
Meghana Karnik-Henry
Meghana Karnik-Henry
Siemens Healthineers
Verified email at siemens-healthineers.com
Title
Cited by
Cited by
Year
Individual differences in the expression of a “general” learning ability in mice
LD Matzel, YR Han, H Grossman, MS Karnik, D Patel, N Scott, SM Specht, ...
Journal of Neuroscience 23 (16), 6423-6433, 2003
2672003
Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia
L Wang, D Mamah, MP Harms, M Karnik, JL Price, MH Gado, ...
Biological psychiatry 64 (12), 1060-1068, 2008
1022008
BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects
MS Karnik, L Wang, DM Barch, JC Morris, JG Csernansky
Psychiatry research 178 (2), 425-429, 2010
752010
Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings
MS Karnik-Henry, L Wang, DM Barch, MP Harms, C Campanella, ...
Schizophrenia research 138 (2-3), 128-135, 2012
662012
Effect of fentanyl on 5‐HT efflux involves both opioid and 5‐HT1A receptors
R Tao, M Karnik, Z Ma, SB Auerbach
British journal of pharmacology 139 (8), 1498-1504, 2003
392003
Acidified sodium chlorite solution: A potential prophylaxis to mitigate impact of multiple exposures to COVID-19 in frontline health-care providers
MS Karnik-Henry
Hospital Practice 48 (4), 165-168, 2020
112020
Medial temporal lobe structure and function
MS Karnik
Washington University in St. Louis, 2009
32009
Combination AED Treatment With Clobazam in Patients With Lennox–Gastaut Syndrome: Post Hoc Analyses of the CONTAIN Study (P4. 264)
SS Chung, BE Gidal, OM Lemming, M Karnik-Henry, E Hackler, D Tolbert, ...
Neurology 90 (15 Supplement), 2018
22018
Persistence to OnabotulinumtoxinA or Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy Among Patients With Migraine: A Retrospective Cohort Study (P10-12.001)
B Talon, C Sullivan, M Karnik-Henry, S Soni-Brahmbhatt, C Anderson, ...
Neurology 100 (17_supplement_2), 3244, 2023
12023
Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment
TJ Schwedt, A Martin, S Kymes, B Talon, XY Lee, R Cady, D Asher, ...
Headache: The Journal of Head and Face Pain 63 (4), 484-493, 2023
12023
CO39 Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment
T Schwedt, A Martin, S Kymes, B Talon, XY Lee, R Cady, D Asher, ...
Value in Health 25 (7), S311, 2022
12022
Characterization of the changes in supine blood pressure with long‐term use of droxidopa in patients with neurogenic orthostatic hypotension
LA Hewitt, A Lindsten, S Gorny, M Karnik‐Henry, S Kymes, A Favit
Health Science Reports 4 (1), e227, 2021
12021
Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment (P7-12.004)
TJ Schwedt, A Martin, S Kymes, B Talon, XY Lee, R Cady, D Asher, ...
Neurology 100 (17 Supplement 2), 2023
2023
Early Clinical Experience With Eptinezumab From a Retrospective, Observational Study of Real-World Patient Response (P6-12.008)
AJ Starling, S Kymes, D Asher, S Soni-Brahmbhatt, M Karnik-Henry
Neurology 100 (17 Supplement 2), 2023
2023
Lack of “wearing off” effect with eptinezumab in the preventive treatment of migraine (P13-12.009)
R Cady, M Karnik-Henry, D Asher, S Soni-Brahmbhatt, DW Dodick
Neurology 100 (17 Supplement 2), 2023
2023
Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States
AJ Starling, S Kymes, D Asher, S Soni-Brahmbhatt, M Karnik-Henry
BMC neurology 23 (1), 158, 2023
2023
Early clinical experience with eptinezumab from a retrospective, observational study of real-world patient response
AJ Starling, S Kymes, D Asher, S Soni-Brahmbhatt, M Karnik-Henry
HEADACHE 62, 136-136, 2022
2022
Changes in Supine Blood Pressure with Long Term Use of Droxidopa
M Karnik-Henry, S Gorny, L Hewitt, A Lindsten, S Kymes, A Favit
MOVEMENT DISORDERS 34, S52-S52, 2019
2019
Changes in Supine Blood Pressure with Long-Term Droxidopa Use
LA Hewitt, S Gorny, A Lindsten, M Karnik-Henry, S Kymes, A Favit
ANNALS OF NEUROLOGY 86, S85-S85, 2019
2019
Glycogen Synthase Kinase 3-Beta and Reduced Gray Matter Volume in Schizophrenia
ME Dokucu, DJ Cobia, MS Karnik-Henry, H Dong, AM Goate, ...
BIOLOGICAL PSYCHIATRY 75 (9), 217S-217S, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20